← SynDRA
MIDAFOTEL
SynDRA canonical compound SYN0003572 — structure-anchored drug synonym record
| Clinical phase | Phase 3 |
| Primary target(s) | GRIN1 | GRIN2A | GRIN2B | GRIN2C | GRIN2D |
| Mechanism of action | glutamate receptor antagonist |
All known targets
- GRIN1
- GRIN2A
- GRIN2B
- GRIN2C
- GRIN2D
Mechanisms of action (all sources)
- glutamate receptor antagonist
Cross-references
Synonyms
- Sdz-eaa-494
- EAA-494
- D-Cpp-ene
- SDZ-EAA 494
- d-cppene
- Midafotel [INN]
- midafotelum
- UNII-7LYU6ZF84G
- 7LYU6ZF84G
- D(-)CPPene
- (R)-CPP-ene
- MIDAFOTEL [WHO-DD]
- DTXCID9025740
- CHEBI:180900
- RefChem:158825
- NCGC00092278-02
- Midafotel, D-CPP-ene
- SCHEMBL1061150
- (R,E)-4-(3-Phosphonoallyl)piperazine-2-carboxylic acid
- (R)-4-((E)-3-Phosphonoallyl)-2-piperazinecarboxylic acid
- (-)-(R)-4-((E)-3-Phosphonoallyl)-2-piperazinecarboxylic acid
- Tox21_111189
- (R)-CPPene (SDZ EAA 494)
- EX-A14446
- HB0023
- AKOS024456500
- NCGC00092278-01
- MS-32768
- HY-107718
- CAS-117414-74-1
- CS-0029299
- NS00126206
- BRD-K45163704-001-01-5
- (R,E)-4-(3-Phosphonoallyl)piperazine-2-carboxylicacid
- (2R)-4-[(E)-3-phosphonoprop-2-enyl]piperazine-2-carboxylic acid
Look up MIDAFOTEL in the interactive SynDRA portal →